Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery
The Long Run with Luke Timmerman - Un pódcast de Timmerman Report
Tariq Kassum, CEO of Cambridge, Mass.-based Celsius Therapeutics, on using single cell technology for drug discovery.
